Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.

Saved in:

Bibliographic Details
Title:	Receptor status change from primary to residual breast cancer after neoadjuvant chemotherapy and analysis of survival outcomes.
Authors:	Parinyanitikul N; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Lei X; Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Chavez-MacGregor M; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Liu S; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Mittendorf EA; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Litton JK; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Woodward W; Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Zhang AH; Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Hortobagyi GN; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Valero V; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Meric-Bernstam F; Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Investigational Cancer Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address: fmeric@mdanderson.org., Gonzalez-Angulo AM; Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
Source:	Clinical breast cancer [Clin Breast Cancer] 2015 Apr; Vol. 15 (2), pp. 153-60. Date of Electronic Publication: 2014 Oct 02.
Publication Type:	Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Elsevier Country of Publication: United States NLM ID: 100898731 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0666 (Electronic) Linking ISSN: 15268209 NLM ISO Abbreviation: Clin Breast Cancer Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1938-0666
DOI:	10.1016/j.clbc.2014.09.006